Lyell Immunopharma, Inc. (LYEL)

21.97 +0.57 (+2.66%) USD  |  NASDAQ  |  Feb 23, 11:26
More

Lyell Immunopharma Current Provisions - Legal & Other (Per Share)

Current Provisions - Legal & Other (Per Share) Chart

View Current Provisions - Legal & Other (Per Share) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Provisions - Legal & Other (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Provisions - Legal & Other (Per Share) Range, Past 5 Years

View Current Provisions - Legal & Other (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Provisions - Legal & Other (Per Share) Benchmarks

View Current Provisions - Legal & Other (Per Share) Benchmarks
Start Trial
Insmed, Inc. --
Nektar Therapeutics --
GT Biopharma, Inc. --
Regeneron Pharmaceuticals, Inc. --
Vertex Pharmaceuticals, Inc. --